Literature DB >> 20861086

A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702).

Tore Stokland1, Jo-Fen Liu, James W Ironside, David W Ellison, Roger Taylor, Kathryn J Robinson, Susan V Picton, David A Walker.   

Abstract

The purpose of this study was to identify risk factors for the progression of low-grade glioma in children from a large population-based cohort. Patient and tumor details of a national cohort of children with low-grade glioma, recruited into an international multidisciplinary clinical strategy, were subjected to univariate and multivariate analyses of progression-free survival and overall survival. From the cohort of 798 patients, 639 patients were eligible, with a median age 6.71 years (0.26-16.75 years); 49% were males; 15.9% had neurofibromatosis type 1, 63.7% pilocytic astrocytoma, 5.9% fibrillary astrocytoma, 4.2% mixed neuronal-glial tumors, and 3.6% others; 21.1% were diagnosed clinically. Anatomically implicated were 31.6% cerebellum, 24.6% chiasma/hypothalamus, 16.0% cerebral hemispheres, 9.9% brain stem, 6.1% other supratentorial midline structures, 5.9% optic nerve only, 4.5% spinal cord, and 1.4% others. The 5-year overall survival and progression-free survival in the whole cohort were 94.6% and 69.4%, respectively. There was a significant association between age and site (P < .001) and extent of tumor resection and site (P < .001). Multivariate analysis identified young age, fibrillary astrocytoma, and extent of surgical resection as significant independent risk factors for progression. Hypothalamic/chiasmatic tumors demonstrated the most sustained tendency to progress. In conclusion, the influence of age and anatomical site upon the risk of tumor progression suggests that these factors strongly influence tumor behavior for the majority of pilocytic tumors. Age <1 year and 1-5 years, fibrillary histology, completeness of resection, and chiasmatic location are candidates for stratification in future studies.

Entities:  

Mesh:

Year:  2010        PMID: 20861086      PMCID: PMC3018938          DOI: 10.1093/neuonc/noq092

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  40 in total

Review 1.  Prognostic factors for progression of childhood optic pathway glioma: a systematic review.

Authors:  Enrico Opocher; Leontien C M Kremer; Liviana Da Dalt; Marianne D van de Wetering; Elisabetta Viscardi; Huib N Caron; Giorgio Perilongo
Journal:  Eur J Cancer       Date:  2006-06-30       Impact factor: 9.162

2.  Epidemiology of pediatric tumors of the nervous system according to the WHO 2000 classification: a report of 1,195 cases from a single institution.

Authors:  Sergio Rosemberg; Dirce Fujiwara
Journal:  Childs Nerv Syst       Date:  2005-07-26       Impact factor: 1.475

3.  Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.

Authors:  Nicole M Warrington; B Mark Woerner; Girish C Daginakatte; Biplab Dasgupta; Arie Perry; David H Gutmann; Joshua B Rubin
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

4.  Outcome analysis of childhood low-grade astrocytomas.

Authors:  Paul G Fisher; Tarik Tihan; Patricia T Goldthwaite; Moody D Wharam; Benjamin S Carson; Jon D Weingart; Michael X Repka; Kenneth J Cohen; Peter C Burger
Journal:  Pediatr Blood Cancer       Date:  2008-08       Impact factor: 3.167

5.  Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin.

Authors:  Mukesh K Sharma; David B Mansur; Guido Reifenberger; Arie Perry; Jeffrey R Leonard; Kenneth D Aldape; Meredith G Albin; Ryan J Emnett; Simon Loeser; Mark A Watson; Rakesh Nagarajan; David H Gutmann
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

Review 6.  Spontaneous regression of low-grade gliomas in pediatric patients without neurofibromatosis.

Authors:  Warren Matthew Rozen; Samuel Joseph; Patrick Anthony Lo
Journal:  Pediatr Neurosurg       Date:  2008-05-27       Impact factor: 1.162

7.  Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene.

Authors:  Angela J Sievert; Eric M Jackson; Xiaowu Gai; Hakon Hakonarson; Alexander R Judkins; Adam C Resnick; Leslie N Sutton; Phillip B Storm; Tamim H Shaikh; Jaclyn A Biegel
Journal:  Brain Pathol       Date:  2008-10-21       Impact factor: 6.508

8.  BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas.

Authors:  Stefan Pfister; Wibke G Janzarik; Marc Remke; Aurélie Ernst; Wiebke Werft; Natalia Becker; Grischa Toedt; Andrea Wittmann; Christian Kratz; Heike Olbrich; Rezvan Ahmadi; Barbara Thieme; Stefan Joos; Bernhard Radlwimmer; Andreas Kulozik; Torsten Pietsch; Christel Herold-Mende; Astrid Gnekow; Guido Reifenberger; Andrey Korshunov; Wolfram Scheurlen; Heymut Omran; Peter Lichter
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

9.  Pilomyxoid astrocytoma: neuroimaging with clinicopathologic correlates in 4 cases followed over time.

Authors:  Sirisha T Komakula; Laura Z Fenton; Bette K Kleinschmidt-DeMasters; Nicholas K Foreman
Journal:  J Pediatr Hematol Oncol       Date:  2007-07       Impact factor: 1.289

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more
  65 in total

1.  BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.

Authors:  Eric H Raabe; Kah Suan Lim; Julia M Kim; Alan Meeker; Xing-Gang Mao; Guido Nikkhah; Jarek Maciaczyk; Ulf Kahlert; Deepali Jain; Eli Bar; Kenneth J Cohen; Charles G Eberhart
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

2.  Pediatric and adult gliomas: how different are they?

Authors:  Ryo Nishikawa
Journal:  Neuro Oncol       Date:  2010-12       Impact factor: 12.300

Review 3.  Malignant transformation in pediatric spinal intramedullary tumors: case-based update.

Authors:  E Winograd; N Pencovich; M Yalon; D Soffer; L Beni-Adani; S Constantini
Journal:  Childs Nerv Syst       Date:  2012-07-10       Impact factor: 1.475

4.  Can we improve accuracy and reliability of MRI interpretation in children with optic pathway glioma? Proposal for a reproducible imaging classification.

Authors:  Julien Lambron; Josué Rakotonjanahary; Didier Loisel; Eric Frampas; Emilie De Carli; Matthieu Delion; Xavier Rialland; Frédérique Toulgoat
Journal:  Neuroradiology       Date:  2015-10-30       Impact factor: 2.804

5.  Metastatic Low-Grade Gliomas in Children: 20 Years' Experience at St. Jude Children's Research Hospital.

Authors:  Omar Chamdine; Alberto Broniscer; Shengjie Wu; Amar Gajjar; Ibrahim Qaddoumi
Journal:  Pediatr Blood Cancer       Date:  2015-08-27       Impact factor: 3.167

6.  Differential imaging characteristics and dissemination potential of pilomyxoid astrocytomas versus pilocytic astrocytomas.

Authors:  Bálint Alkonyi; Johannes Nowak; Astrid K Gnekow; Torsten Pietsch; Monika Warmuth-Metz
Journal:  Neuroradiology       Date:  2015-02-10       Impact factor: 2.804

Review 7.  Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

Authors:  Guillaume Bergthold; Pratiti Bandopadhayay; Wenya Linda Bi; Lori Ramkissoon; Charles Stiles; Rosalind A Segal; Rameen Beroukhim; Keith L Ligon; Jacques Grill; Mark W Kieran
Journal:  Biochim Biophys Acta       Date:  2014-02-28

8.  Challenges in the management of childhood low-grade glioma in a developing country.

Authors:  Khalid Abdalla; Shaker Abdullah; Abeer Almehdar; Naglla Elimam; Mohammed Burhan Abrar; Wasil Jastaniah
Journal:  Childs Nerv Syst       Date:  2018-02-02       Impact factor: 1.475

9.  Satellite lesions of DNET: implications for seizure and tumor control after resection.

Authors:  Jeyul Yang; Seung-Ki Kim; Ki Joong Kim; Jong Hee Chae; Byung Chan Lim; Kyu-Chang Wang; Sung-Hye Park; Ji Hoon Phi
Journal:  J Neurooncol       Date:  2019-05-03       Impact factor: 4.130

10.  Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas.

Authors:  Kohei Fukuoka; Yasin Mamatjan; Ruth Tatevossian; Michal Zapotocky; Scott Ryall; Ana Guerreiro Stucklin; Julie Bennett; Liana Figueiredo Nobre; Anthony Arnoldo; Betty Luu; Ji Wen; Kaicen Zhu; Alberto Leon; Dax Torti; Trevor J Pugh; Lili-Naz Hazrati; Normand Laperriere; James Drake; James T Rutka; Peter Dirks; Abhaya V Kulkarni; Michael D Taylor; Ute Bartels; Annie Huang; Gelareh Zadeh; Kenneth Aldape; Vijay Ramaswamy; Eric Bouffet; Matija Snuderl; David Ellison; Cynthia Hawkins; Uri Tabori
Journal:  Neuro Oncol       Date:  2020-10-14       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.